ST Elevated Myocardial Infarction
Conditions
Keywords
Complication, Primary Percutaneus Coronary Intervention, Radial Artery, Ulnar Artery
Brief summary
In the literature, there are no studies comparing these two pathways in ST elevation myocardial infarction (STEMI). In this patient group, it will be investigated whether transulnar intervention causes similar or less complications than transradial intervention, and whether it provides superiority or similarity in terms of outcomes.
Detailed description
The transulnar approach is known as an alternative procedure for transradial coronary angiography due to its safety and applicability. For cardiologists, experienced in trans-ulnar access, this access zone is comfortable to use. Because less spasm is developing. In addition, no significant difference was found between the transradial and transulnar routes in terms of other complications.In the literature, there are no studies comparing these two pathways in ST elevation myocardial infarction (STEMI). In this patient group, it will be investigated whether transulnar intervention causes similar or less complications than transradial intervention, and whether it provides superiority or similarity in terms of outcomes.
Interventions
primary percutaneous coronary intervention via transulnar or transradial access
Sponsors
Study design
Intervention model description
Patients admitted with STEMI at the cardiology department and admitted to the catheter laboratory for primary percutaneous coronary intervention will be included in the study. There will be two groups in the study.In the first group, patients treated with transulnar access will be included. In the second group, patients using transradial access will be included. Patients will be treated by the same operator respectively. Peri-procedural data and in-hospital cardiac outcome data of patients in both groups will be recorded.
Eligibility
Inclusion criteria
* patients over 18 years of age * admitted for primary percutaneous intervention * either of these two routes has not been used in the last week * a sufficient pulse at both routes
Exclusion criteria
* cardiogenic shock * stent thrombosis * the use of either of these two arteries in the last 1 week * either of these arteries can not be pulsed or very weak pulsed
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complication rate | 1 day | Major and minor neurovascular events (access related) of the arm including pain/motor paralysis/paresthesia, hematoma, pseudoaneurysm, artery spasm, arterial occlusion |
| in-hospital cardiac outcomes | 1 week | the incidence of death, myocardial infarction (MI), urgent target lesion revascularization (TLR), acute heart failure as major adverse cardiac events (MACEs) within the hospital |
Countries
Turkey (Türkiye)